Swiss pharma giant Novartis buying U.S.-based Endocyte in $2.1B deal
Thursday, October 18, 2018 - 08:20
in Mathematics & Economics
Novartis, one of the world's largest pharmaceutical companies, said Thursday it will buy U.S. biopharmaceutical firm Endocyte in a $2.1 billion deal.